Summary
To assess the value of the paramagnetic contrast agent Gadolinium (Gd)-DTPA in Magnetic Resonance Imaging (MRI) of acute myocardial infarction (AMI), we studied 20 patients with a first AMI by ECG-gated MRI before and after intravenous administration of 0.15mmol/kg Gd-DTPA. The MRI studies were performed after a mean of 98 hours (range 15–241) after the acute onset of AMI. Spin-echo measurements (TE 30 msec) were made using a Philips Gyroscan (0.5 Tesla). After performing the baseline MRI scans, the MRI procedure was repeated every 10 minutes for up to 40 minutes following injection of Gd-DTPA. In 18 (90%) patients contrast enhancement in the infarcted myocardial areas was observed after Gd-DTPA. In these patients intensity versus region curves, derived from 9 to 11 adjacent myocardial regions of interest, showed increased signal intensities in the infarcted areas after administration of Gd-DTPA. The precontrast signal intensity ratio between infarcted and normal myocardium was 1.14±0.15 (mean±SD); the postcontrast ratios at 10 minutes were 1.41±0.21 (P <0.05), at 20 minutes 1.61±0.19 (P <0.01), at 30 minutes 1.43±0.20 (P < 0.05), and at 40 minutes 1.33±0.20 (P=NS). It is concluded that MRI using the contrast agent Gd-DTPA significantly improves the visualization and detection of infarcted myocardial areas in patients with AMI and that optimal contrast enhancement is obtained 20 minutes after administration of Gd-DTPA.
Similar content being viewed by others
References
Filipchuck NG, Peshock RM, Malloy CR, Corbett JR, Rehr RB, Buja LM, Jansen DE, Redish GR, Gabliani GI, Parkey RW, Willerson JT. Detection and localization of recent myocardial infarction by Magnetic Resonance Imaging. Am J Cardiol 1986; 58: 214–9.
Checkley D, Loveday BE, Waterton JC, Zhu XP, Isherwood I. Detection of myocardial infarction in the mini-pig using NMR imaging. Magn Res Med 1987; 5: 201–16.
White RD, Cassidy MM, Melvin D, Emilson B, Ports TA, Lim AD, Botvinick EH, Schiller NB, Higgins CB. Segmental evaluation of left ventricular wall motion after myocardial infarction: Magnetic resonance imaging versus echocardiography. Am Heart J 1988; 115: 166–75.
White RD, Holt WW, Cheitlin MD, Cassidy MM, Ports TA, Lim AD, Botvinick EH, Higgins CB. Estimation of the functional and anatomic extent of myocardial infarction using magnetic resonance imaging. Am Heart J 1988; 115: 740–8.
Underwood SR, Rees RSO, Savage PE, Klipstein RH, Firmin DN, Fox KM, Poole-Wilson PA, Longmore DB. Assessment of regional left ventricular function by magnetic resonance. Br Heart J 1987; 56: 334–40.
McNamara MT, Higgins CB, Schechtmann N, Botvinick E, Lipton MJ, Chatteree K, Amparo EG. Detection and characterization of acute myocardial infarction in man with the use of gated magnetic resonance. Circulation 1985; 71:717–24.
Been M, Ridgeway JP, Douglas RHB, Best JJK, Smith MA, Brydon JWE, Kean DM, Muir AL. Characterisation of acute myocardial infarction by gated magnetic resonance imaging. Lancet 1985; ii: 348–50.
Canby RC, Reeves RC, Evanochko WT, Elgavish GA, Pohost GM. Proton nuclear magnetic resonance relaxation times in severe myocardial ischemia. J Am Coll Cardiol 1987; 10: 412–20.
Been M, Smith MA, Ridgeway JP, Douglas RHB, De Bono DP, Best JJK, Muir A. Serial changes in the T1 magnetic relaxation parameter after myocardial infarction in man. Br Heart 1988; 59: 1–8.
Wesbey G, Higgins CB, Lanzer P, Botvinick E, Lipton M. Imaging and characterization of acute myocardial infarction in vivo by gated nuclear magnetic resonance. Circulation 1984; 69: 125–30.
Johnston DL, Thompson RC, Liu P, Dinsmore RE, Wismer GL, Saini S, Kaul S, Rosen BR, Brady TJ, Okada RD. Magnetic resonance imaging during acute myocardial infarction. Am J Cardiol 1986; 57: 1059–65.
De Roos A. Clinical application of Gadolinium-DTPA in Magnetic Resonance Imaging. In: Kressel H, ed: Resonance imaging annual. New York: Raven Press, 1988:113–45.
Wesbey GE, Higgins CB, McNamara MT, Engelstad BL, Lipton MJ, Sievers R, Ehman RL, Lovin J, Brasch RC. Effect of Gadolinium-DTPA on the magnetic relaxation times of normal and infarcted myocardium. Radiology 1984; 153: 165–9.
Runge VM, Clanton JA, Wehr CJ, Partain CL, James AE. Gated magnetic resonance imaging of acute myocardial ischemia in dogs: application of multiecho techniques and contrast enhancement with GD DTPA. Magn Reson Imaging 1984; 3: 255–66.
Rehr RB, Peshock RM, Malloy CR, Keller AM, Parkey RW, Buja LM, Nunnally RL, Willerson JT. Improved in vivo magnetic resonance imaging of acute myocardial infarction after intravenous paramagnetic contrast agent administration. Am J Cardiol 1986; 57: 864–8.
Nishimura T, Yamada Y, Kozuka T, Nakatani T, Noda H, Takano H. Value and limitation of Gadolinium-DTPA contrast enhancement in the early detection of acute canine myocardial infarction. Am J Physiolo 1987; 2: 181–5.
Johnston DL, Liu P, Lauffer RB, Newell JB, Van Weeden J, Rosen BR, Brady TJ, Okada RD. Use of Gadolinium-DTPA as a myocardial perfusion agent: potential applications and limitations for magnetic resonance imaging. J Nucl Med 1987; 28: 871–7.
McNamara MT, Higgins CB, Ehman RL, Revel D, Sievers R, Brasch RC. Acute myocardial ischemia: Magnetic resonance contrast enhancement with Gadolinium-DTPA. Radiology 1984; 153: 157–63.
De Roos A, Doornbos J, Van der Wall EE, Van Voorthuisen AE. MR imaging of acute myocardial infarction: Value of Gd-DTPA. Am J Rontgenol 1987; 150: 531–4.
Van der Laarse A, Hermens WTh, Hollaar L, Jol M, Willems GM, Lemmers HEAS, Liem AH, Souverijn JHM, Oudhof JH, De Hooge J, Buis B, Arntzenius AC. Assessment of myocardial damage in patients with acute myocardial infarction by serial measurement of serum alpha-hydroxybutyrate dehydrogenase (HBDH)-levels. Am Heart J 1984; 107: 248–60.
Ahmad M, Johnson RF, Fawcett D, Schreibert MH. Magnetic resonance imaging in patients with unstable angina: comparison with acute myocardial infarction and normals. Magn Reson Imaging 1988; 6: 527–34.
Eichstaedt HW, Felix R, Dougherty FC, Langer M, Rusch W, Schmutzler H. Magnetic Resonance Imaging (MRI) in different stages of myocardial infarction using the contrast agent Gadolinium-DTPA. Clin Cardiol 1986; 9: 527–35.
Peshock RM, Malloy CR, Buja M, Nunnally RL, Parkey RW, Willerson JT. Magnetic resonance imaging of acute myocardial infarction: gadolinium diethylenetriamine pentaacetic acid as a marker of reperfusion. Circulation 1986; 74:1434–40.
McNamara MT, Tscholakoff D, Revel D, Soulen R, Schechtmann N, Botvinick E, Higgins CB. Differentiation of reversible and irreversible myocardial injury by MR imaging with and without Gadolinium-DTPA. Radiology 1986; 158: 765–9.
Tscholakoff D, Higgins CB, Sechtem U, McNamara MT. Occlusive and reperfused myocardial infarcts: effect of Gadolinium-DTPA on ECG-gated magnetic resonance imaging. Radiology 1986; 160: 515–9.
Wisenberg G, Prato FS, Carroll SE, Turner KL, Marshall T. Serial nuclear magnetic resonance imaging of acute myocardial infarction with and without reperfusion. Am Heart J 1988; 115: 510–8.
Weinmann H-J, Brasch RC, Press W-R, Wesbey GE. Characteristics of gadolinium-DTPA complex: a potential NMR contrast agent. Am J Rontgenol 1984; 142: 619–24.
Schaefer S, Malloy CR, Katz J, Parkey RW, Buja M, Willerson JT, Peshock RM. Gadolinium-DTPA-enhanced nuclear magnetic resonance imaging of reperfused myocardium: Identification of the myocardial bed at risk. J Am Coll Cardiol 1988; 12: 1064–72.
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
van Dijkman, P.R.M., Doornbos, J., de Roos, A. et al. Improved detection of acute myocardial infarction by magnetic resonance imaging using Gadolinium-DTPA. Int J Cardiac Imag 5, 1–8 (1989). https://doi.org/10.1007/BF01745226
Issue Date:
DOI: https://doi.org/10.1007/BF01745226